{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:03:54Z","timestamp":1781024634859,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":67,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008732","name":"The Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016589","name":"Tokyo Metropolitan Institute of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004721","name":"The University of Tokyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K10435"],"award-info":[{"award-number":["JP24K10435"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K08692"],"award-info":[{"award-number":["JP21K08692"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K08404"],"award-info":[{"award-number":["JP21K08404"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K08657"],"award-info":[{"award-number":["JP18K08657"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K11549"],"award-info":[{"award-number":["JP24K11549"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012832","name":"Okinaka Memorial Institute for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012832","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005731","name":"Juntendo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008670","name":"Terumo Foundation for Life Sciences and Arts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.100922","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:25:45Z","timestamp":1773458745000},"page":"100922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting Clinical Response to Granulocyte\/Monocyte Adsorption Apheresis in Treatment-Resistant Ulcerative Colitis"],"prefix":"10.1016","volume":"5","author":[{"given":"Shintaro","family":"Yano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Osada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-3410","authenticated-orcid":false,"given":"Makoto","family":"Furihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Heissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Nagahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2026.100922_bib1","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/bloodadvances.2023011756","article-title":"Effectiveness and safety of prophylactic anticoagulation among hospitalized patients with inflammatory bowel disease","volume":"8","author":"Dawwas","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.gastha.2026.100922_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jcgh.2003.50005","article-title":"Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study","volume":"1","author":"Hanai","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.100922_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000080079","article-title":"Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis","volume":"70","author":"Hanai","year":"2004","journal-title":"Digestion"},{"key":"10.1016\/j.gastha.2026.100922_bib4","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jca.22091","article-title":"Adsorptive cytapheresis in ulcerative colitis: a non-pharmacological therapeutic approach revisited","volume":"38","author":"Vernia","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.gastha.2026.100922_bib5","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ecco-jcc\/jjaa051","article-title":"Efficacy of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease showing lost response to infliximab","volume":"14","author":"Yokoyama","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastha.2026.100922_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/00365521.2019.1600715","article-title":"Granulocyte-monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis","volume":"54","author":"Rodr\u00edguez-Lago","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.100922_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jca.20053","article-title":"In vitro and in vivo evaluation of adacolumn cytapheresis in healthy subjects","volume":"20","author":"Ramlow","year":"2005","journal-title":"J Clin Apher"},{"key":"10.1016\/j.gastha.2026.100922_bib8","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.100922_bib9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn's disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastha.2026.100922_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/CEG.S293272","article-title":"Anti-integrins for the treatment of inflammatory bowel disease: current evidence and perspectives","volume":"14","author":"Gubatan","year":"2021","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.gastha.2026.100922_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41575-018-0084-8","article-title":"IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting","volume":"16","author":"Moschen","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.100922_bib12","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/S0140-6736(21)00666-8","article-title":"Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b\/3 double-blind, randomised, placebo-controlled trial","volume":"397","author":"Feagan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.gastha.2026.100922_bib13","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/ibd\/izac200","article-title":"Systematic review and meta-analysis: loss of response and need for dose escalation of infliximab and adalimumab in ulcerative colitis","volume":"29","author":"Savelkoul","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastha.2026.100922_bib14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0016-5085(99)70339-2","article-title":"Matrix metalloproteinase levels are elevated in inflammatory bowel disease","volume":"117","author":"Baugh","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.100922_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11596-018-1873-6","article-title":"WGCNA reveals key roles of IL8 and MMP-9 in progression of involvement area in colon of patients with ulcerative colitis","volume":"38","author":"Lin","year":"2018","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.gastha.2026.100922_bib16","first-page":"765","article-title":"Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration","volume":"25","author":"Heissig","year":"2010","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.gastha.2026.100922_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109761","article-title":"The multifaceted role of plasminogen in inflammation","volume":"75","author":"Heissig","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.gastha.2026.100922_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1572-0241.2006.00943.x","article-title":"Inflammation and coagulation in inflammatory bowel disease: the clot thickens","volume":"102","author":"Danese","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.100922_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3390\/cells12030445","article-title":"The role of the plasminogen\/plasmin system in inflammation of the oral cavity","volume":"12","author":"Yatsenko","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.gastha.2026.100922_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/j.gastro.2014.12.001","article-title":"Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells","volume":"148","author":"Munakata","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.100922_bib21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/330662a0","article-title":"Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia","volume":"330","author":"Tracey","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.gastha.2026.100922_bib22","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0016-5085(94)90398-0","article-title":"Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease","volume":"106","author":"Breese","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.100922_bib23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.gastha.2026.100922_bib24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41419-019-1808-6","article-title":"Inhibition of transmembrane TNF-\u03b1 shedding by a specific antibody protects against septic shock","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gastha.2026.100922_bib25","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/gutjnl-2014-307477","article-title":"Comparing histological activity indexes in UC","volume":"64","author":"Bressenot","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.gastha.2026.100922_bib26","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3390\/jcm10184219","article-title":"Inflammatory bowel disease and neutrophil-lymphocyte ratio: a systematic scoping review","volume":"10","author":"Langley","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastha.2026.100922_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231988","article-title":"Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with ulcerative colitis","volume":"15","author":"Yamamoto-Furusho","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.gastha.2026.100922_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6517549","article-title":"Correlation between serological biomarkers and disease activity in patients with inflammatory bowel disease","volume":"2019","author":"Xu","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.gastha.2026.100922_bib29","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.938827","article-title":"Neutrophil-to-platelet ratio in patients with ulcerative colitis treated with infliximab or vedolizumab: a retrospective, single-center study in Poland","volume":"29","author":"Warpechowski","year":"2023","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.gastha.2026.100922_bib30","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastha.2026.100922_bib31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1744-9987.12212","article-title":"Relationship between tumor necrosis factor-\u03b1 release and granulocyte and monocyte adsorption to cellulose acetate beads","volume":"18","author":"Nishise","year":"2014","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.gastha.2026.100922_bib32","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.gastha.2026.100922_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jcla.21564","article-title":"Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis","volume":"27","author":"Celikbilek","year":"2013","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.gastha.2026.100922_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000336995","article-title":"The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases","volume":"30","author":"Lakatos","year":"2012","journal-title":"Dig Dis"},{"key":"10.1016\/j.gastha.2026.100922_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ecco-jcc\/jjv005","article-title":"The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases","volume":"9","author":"Farkas","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastha.2026.100922_bib36","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1097\/MCG.0000000000000837","article-title":"Fecal matrix metalloprotease-9 and lipocalin-2 as biomarkers in detecting endoscopic activity in patients with inflammatory bowel diseases","volume":"52","author":"Buisson","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastha.2026.100922_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155410","article-title":"Granulocyte and monocyte adsorptive apheresis induces apoptosis of neutrophils and release of a novel chemoattractant for desensitization of interleukin-8 response\u2014in vitro and in vivo results","volume":"139","author":"Kashiwagi","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.gastha.2026.100922_bib38","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1053\/j.gastro.2005.09.017","article-title":"Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP","volume":"129","author":"Castaneda","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.100922_bib39","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cgh.2021.07.005","article-title":"Early change in epithelial neutrophilic infiltrate predicts long-term response to biologics in ulcerative colitis","volume":"20","author":"Narula","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.100922_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127063","article-title":"Selective allosteric inhibition of MMP9 is efficacious in preclinical models of ulcerative colitis and colorectal cancer","volume":"10","author":"Marshall","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.gastha.2026.100922_bib41","doi-asserted-by":"crossref","first-page":"G988","DOI":"10.1152\/ajpgi.00256.2015","article-title":"Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis","volume":"309","author":"Nighot","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.gastha.2026.100922_bib42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/15258160260090979","article-title":"Proteolytic enzyme levels are increased during granulocyte colony-stimulating factor-induced hematopoietic stem cell mobilization in human donors but do not predict the number of mobilized stem cells","volume":"11","author":"van Os","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.gastha.2026.100922_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(02)00754-7","article-title":"Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand","volume":"109","author":"Heissig","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.gastha.2026.100922_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ebiom.2016.02.011","article-title":"Complement activation in arterial and venous thrombosis is mediated by plasmin","volume":"5","author":"Foley","year":"2016","journal-title":"EBiomedicine"},{"key":"10.1016\/j.gastha.2026.100922_bib45","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1182\/blood-2005-08-3176","article-title":"Increased soluble urokinase plasminogen activator receptor (suPAR) serum levels after granulocyte colony-stimulating factor treatment do not predict successful progenitor cell mobilization in vivo","volume":"107","author":"Fietz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.gastha.2026.100922_bib46","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1023\/A:1015330816364","article-title":"Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis","volume":"47","author":"Kashiwagi","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastha.2026.100922_bib47","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s00535-004-1464-0","article-title":"Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis","volume":"39","author":"Andoh","year":"2004","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.100922_bib48","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1572-0241.2004.30432.x","article-title":"Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis","volume":"99","author":"Hanai","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.100922_bib49","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","article-title":"AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis","volume":"164","author":"Singh","year":"2023","journal-title":"Gastroenterology"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:50:08Z","timestamp":1781023808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326000439"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.100922","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting Clinical Response to Granulocyte\/Monocyte Adsorption Apheresis in Treatment-Resistant Ulcerative Colitis","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.100922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"100922"}}